AC
CTLT icon

Armistice Capital’s CATALENT, INC. CTLT Stock Holding History

Armistice Capital’s Portfolio CTLT Stock Details CTLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-125,260
Closed -$7.07M – 397
2024
Q1 		$7.07M Buy
+125,260
New +$6.78M 0.09% 111

Other funds holding CTLT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Armistice Capital's CTLT Position: Q2 2024 in Review

Armistice Capital sold out of CATALENT, INC. (CTLT) in Q2 2024, closing a stake of 125,260 shares — an estimated $7.07M sold.

Armistice Capital first reported a position in CTLT in Q1 2024 and held it in 1 quarter. The position peaked at $7.07M in Q1 2024. 448 funds tracked by Wall St. Rank hold CTLT as of Q2 2024.

  • Armistice Capital reported no remaining CATALENT, INC. position as of Q2 2024 after selling out during the quarter.
  • Armistice Capital sold 125,260 CATALENT, INC. shares in Q2 2024, an estimated $7.07M.
  • Armistice Capital first reported a position in CATALENT, INC. in Q1 2024 and held it in 1 quarter.
  • Armistice Capital's CATALENT, INC. position peaked at $7.07M in Q1 2024.
  • 448 funds tracked by Wall St. Rank held CATALENT, INC. as of Q2 2024.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.